ClinicalTrialsFinder

Metastatic Cholangiocarcinoma Clinical Trials in San Francisco, California

1 recruitingSan Francisco, California

Showing 1–1 of 1 trials

Recruiting
Phase 1

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations

Solid TumorIntrahepatic CholangiocarcinomaLocally Advanced Cholangiocarcinoma+1 more
Tyra Biosciences, Inc40 enrolled4 locationsNCT06160752